Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.
about
Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvementMolecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular trafficScleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathologyAnti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.The Clinical Features of Myositis-Associated Autoantibodies: a Review.Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis.The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases.Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc.European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.Bench to bedside review of myositis autoantibodies.
P2860
Q26995764-B0B598C3-A397-4D82-B1B0-C7A7644A86FAQ28392425-8314F02A-D2F5-45A2-81F2-591C51984444Q33765558-9BA81708-A5B1-4880-A17C-AD692F5CD99FQ35532333-CE076AA9-09F9-479B-B902-BB69A661FCEBQ36493693-39EE8C89-04A5-4E73-B64F-8143FD882082Q37226360-C31D10EC-13D4-40F8-9D91-813A5F2670AFQ38603422-98DDE831-4BA0-421E-A1C2-750A1B2AA37CQ39100245-69B99BCC-FFD8-47F6-A5B8-AC72934FA9FFQ39198820-3F495C00-D1BC-47C5-9036-CDEA5AAC83B5Q47238136-0F63CA04-AF2F-4998-9B1B-B8A453F1DB1FQ47634882-0796F48E-CAB4-473C-822B-8B192C85E62EQ49072027-6AD1C9EA-536A-4784-87B1-3CB09340CD34Q55069247-A95623B1-D9A9-4132-BD9C-EE4223DDCCD7Q55425108-BB0AD0B5-AD9A-4FEA-B7A4-52B196709E64
P2860
Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Autoantibodies to RuvBL1 and R ...... d skeletal muscle involvement.
@en
Autoantibodies to RuvBL1 and R ...... d skeletal muscle involvement.
@nl
type
label
Autoantibodies to RuvBL1 and R ...... d skeletal muscle involvement.
@en
Autoantibodies to RuvBL1 and R ...... d skeletal muscle involvement.
@nl
prefLabel
Autoantibodies to RuvBL1 and R ...... d skeletal muscle involvement.
@en
Autoantibodies to RuvBL1 and R ...... d skeletal muscle involvement.
@nl
P2093
P2860
P356
P1476
Autoantibodies to RuvBL1 and R ...... nd skeletal muscle involvement
@en
P2093
Andrew Schnure
Fumihide Ogawa
Kana Hoshino
Kazuhiko Takehara
Kenzou Kaji
Manabu Fujimoto
Mary Lucas
Masataka Kuwana
Noreen Fertig
Shinichi Sato
P2860
P304
P356
10.1002/ACR.22163
P577
2014-04-01T00:00:00Z